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INTRODUCTION
The protein P23, also referred to as ‘P21’ (Chitpatima et al.,
1988; Yenofsky et al., 1982), ‘Q23’ (Thomas and Luther, 1981;
Thomas, 1986) or ‘translationally controlled tumour protein’,
TCTP (Gross et al., 1989), was discovered independently by
three groups in search of translationally regulated proteins. The
mRNA of ‘P21’ has been found to be highly represented in
untranslated mRNP particles of a mouse sarcoma cell line
(Yenofsky et al., 1983) and of mouse erythroleukaemia cells
(Yenofsky et al., 1982). ‘Q23’ was discovered in Swiss 3T3
cells to be one of a number of proteins whose synthesis is
drastically up-regulated after serum stimulation (Thomas and
Luther, 1981; Thomas, 1986) and, later, P23 was identified as
a protein whose rate of synthesis is greatly enhanced in
growing versus non-growing Ehrlich ascites tumour cells
(Benndorf et al., 1988; Böhm et al., 1989). Investigations in
different laboratories showed that P23 synthesis is regulated at
the translational level (Böhm et al., 1989, 1991; Thomas, 1986;
Thomas and Luther, 1981; Yenofsky et al., 1982), and our own
study demonstrated that the activity of initiation factor eIF-4E
is important for P23 mRNA translation (Bommer et al., 1994).
The genomic sequence of rabbit TCTP/P23 was recently
published by Thiele et al. (1998). This study revealed that the
5¢ -flanking region of the P23 gene contains promoter elements
for a variety of transcription factors, indicating that P23
expression is also regulated at the transcriptional level. Indeed,
two recent reports noted considerable alterations of TCTP/P23
mRNA levels in response to changes in cellular conditions
(Stürzenbaum et al., 1998; Sage-Ono et al., 1998).
The first P23 cDNA sequences from mouse (Chitpatima et
al., 1988) and man (Gross et al., 1989) were published a decade
ago, and recent compilations of P23 sequences revealed a high
degree of conservation between all eukaryotic phyla (see e.g.
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The translationally controlled protein P23 was discovered
by the early induction of its rate of synthesis after
mitogenic stimulation of mouse fibroblasts. P23 is
expressed in almost all mammalian tissues and it is highly
conserved between animals, plants and yeast. Based on its
amino acid sequence, P23 cannot be attributed to any
known protein family, and its cellular function remains to
be elucidated. Here, we present evidence that P23 has
properties of a tubulin binding protein that associates with
microtubules in a cell cycle-dependent manner. (1) P23 is a
cytoplasmic protein that occurs in complexes of 100-150
kDa, and part of P23 can be immunoprecipitated from
HeLa cell extracts with anti-tubulin antibodies. (2) In
immunolocalisation experiments we find P23 associated
with microtubules during G1, S, G2 and early M phase of
the cell cycle. At metaphase, P23 is also bound to the mitotic
spindle, and it is detached from the spindle during
metaphase-anaphase transition. (3) A GST-P23 fusion
protein interacts with a - and b -tubulin, and recombinant
P23 binds to taxol-stabilised microtubules in vitro. The
tubulin binding domain of P23 was identified by mutational
analysis; it shows similarity to part of the tubulin binding
domain of the microtubule-associated protein MAP-1B. (4)
Overexpression of P23 results in cell growth retardation
and in alterations of cell morphology. Moreover, elevation
of P23 levels leads to microtubule rearrangements and to
an increase in microtubule mass and stability.
Key words: Translationally controlled tumour protein (TCTP), P23,
Tubulin binding, Microtubule, Cell cycle, Immunolocalisation,
Overexpression
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Sanchez et al., 1997). P23 is a widely expressed protein, as can
be seen from the compilation of EST databases where it was
identified as being expressed in 26 out of 30 human tissues
(Adams et al., 1995). This is in line with the results of a recent
northern blot screening of 43 different human organs (B.-J.
Thiele, personal communication), of immunohistochemical
investigations of human cell lines and tissues (Sanchez et al.,
1997) and of a western blot screening of rat organs (B. Sawitzki
and U.-A. Bommer, unpublished observation). The high
conservation and nearly ubiquitous expression of P23 indicated
that it is an important cellular protein. However, similarity
searches in protein databases did not reveal a relationship of
P23 to any of the known protein families, nor did they provide
any other clue to the potential function of the protein.
An ‘extracellular function’ of P23 has been described
recently, i.e. its activity as an IgE-dependent histamine-
releasing factor in connection with certain allergic diseases
(MacDonald et al., 1995). Other reports indicated that P23 is
involved in triggering the interleukin-4 secretion from human
basophils (Schröder et al., 1996) and that P23 synthesis from
basophils is increased after stimulation with IL-3 or anti-IgE
(Nielsen et al., 1998). Recently, the Plasmodium falciparum
homologue of P23 has been described as a possible target for
the anti-malarial drug artemisinin (Bhisutthibhan et al., 1998).
However, all these investigations did not address the question
of the intracellular function of P23. The possibility that P23
has properties of a calcium-binding protein was suggested
(Sanchez et al., 1997), based on an earlier report on the
calcium-binding activity of a similar protein from
trypanosomes (Haghighat and Ruben, 1992). Various papers
reported the early up-regulation of P23 synthesis after growth-
induction of mammalian cell lines (Thomas and Luther, 1981;
Böhm et al., 1989; Bommer et al., 1994), suggesting an
involvement of the protein in growth-related processes.
Here, we present both in vitro and in vivo evidence showing
that P23 has properties of a tubulin binding protein. By
immunolocalisation experiments we show that P23 associates
with microtubules in a cell cycle-dependent manner, and that
it is bound to the mitotic spindle. We demonstrate that
overexpression of P23 affects both the properties of the
microtubular network and cell growth and morphology.
MATERIALS AND METHODS
Construction of plasmids
The mouse P23 expression vector pT7.7-P23 was prepared by Dr M.
A. Greagg in our laboratory by subcloning the mouse P23 coding
region from the plasmid pRK23-3-5 into the NdeI/BamHI cloning site
of the bacterial expression vector pT7.7. The plasmid pRK23-3-5 had
been generated by Dr M. Gaestel after introducing an NdeI site at the
start of the P23 coding region. The P23 cDNA sequence in these
constructs originated from the primary clone obtained in the
laboratory of Dr G. Brawerman (Chitpatima et al., 1988). The vector
pGEX 2T6 ¢, which contains a suitable in-frame NdeI site at the end
of the GST coding region, was kindly provided by Dr V. Baldin. The
coding region of mouse P23 was cut out from the plasmid pT7.7-P23
by restriction with NdeI/BamHI and subcloned into this vector using
the bacterial strain E. coli JA226. The resulting plasmid pGEX-P23
was shown to express the GST-P23 fusion protein.
Truncated mutant versions of GST-P23, as represented in Fig. 4B,
were generated as follows. PCR fragments comprising a 5¢ -terminal
BamHI site and a 3¢ -terminal XhoI site adjacent to the P23-cDNA
sequence coding for amino acid residues 1-130 (mutant P23-D 3), 70-
130 (mutant P23- D 1/3) and 130-172 (mutant P23- D 1/2), respectively,
were synthesised using the following pairs of primers: 5 ¢ CGC GGA
TCC ATG ATC ATC TAC CGG GAC CTC 3¢ and 5 ¢ CCG CTC GAG
CGG ATT GAA ATT AGC AAG GAT 3 ¢ (mutantP23-D 3); 5¢ CGC
GGA TCC GAC ATT GTC ATG AAC CAT 3 ¢ and 5 ¢ CCG CTC GAG
CGG ATT GAA ATT AGC AAG GAT 3 ¢ (mutantP23- D 1/3); and 5 ¢
CGC GGA TCC ACC TAC CAG TTT TTT ATT GGT GAA 3 ¢ and
5¢ CCG CTC GAG ACA TTT CTC CAT CTC TAA GCC 3 ¢
(mutantP23-D 1/2). The PCR-fragments were cloned in-frame with the
GST coding region into the BamHI/XhoI restriction sites of the vector
pGEX 4T. The plasmid PIM4.4 (provided by Dr D. Templeton) was
originally obtained by a two-hybrid screen experiment. It contains the
human P23 coding sequence starting from about amino acid position
55 subcloned into the pGEX vector system. This construct is here
referred to as GST-P23(D 1-55) and was employed as an additional,
N-terminally truncated, GST-P23 mutant protein.
Protein expression and purification
The plasmid pT7.7-P23 was transfected into E. coli BL21(DE3), and
the pGEX constructs into E. coli JA226. The bacteria were grown
overnight in brain heart broth medium and induced for 6 hours by 0.1
mM IPTG. Then, the cells were collected by centrifugation and
homogenised by sonication. The GST-fusion proteins, as well as
unconjugated GST, were purified on glutathione-agarose beads and
eluted with the following buffer: 10 mM Tris-HCl, pH 8.0, 10 mM
glutathione, 100 mM NaCl, 1 mM PMSF. The proteins were then
equilibrated against 10 mM Tris-HCl, pH 8.0, 50 mM NaCl by gel
filtration through a PD-10 column (Pharmacia). Recombinant P23 was
purified from the bacterial extract by ammonium sulphate
fractionation (45-75%) followed by chromatography on DEAE
Sephadex-A25 in the following buffer: 50 mM Tris-HCl, pH 8.0, 1
mM EDTA, 0.5 mM dithiothreitol, 1 mM PMSF. The elution was
performed using the same buffer containing 200 mM NaCl. The
sample was passed through a Sephadex-G50 column adjusted to the
following buffer conditions: 25 mM sodium acetate, pH 5.35, 1 mM
EDTA, 0.5 mM dithiothreitol, 1 mM PMSF. The protein was adsorbed
to an S-Sepharose column (1· 5 cm) and eluted with 80 mM NaCl, all
in the same buffer. Before storage in liquid nitrogen, the pH was
adjusted to 8.0.
Antibodies
The preparation of polyclonal rabbit antibodies against peptides P2
(residues 98-113) and P3 (C terminus, residues 161-172) of mouse
P23 was described earlier (Bommer et al., 1994). Polyclonal
antibodies against murine purified recombinant P23 were raised in
rabbits. All these antibodies were suitable for detecting P23 on
western blots. For immunofluorescence microscopy, the rabbit
antipeptide antibody (P2) was affinity-purified by chromatography on
GST-P23 crosslinked to CNBr-activated Sepharose. After washing the
column with PBS containing 0.5 M NaCl, the antibody was eluted
with 0.1 M glycine, pH 2.4, and the pH was immediately adjusted to
neutral with 1 M Tris buffer, pH 8.0. A mouse monoclonal antibody
against human TCTP/P23 was kindly provided by Dr J.-C. Sanchez
(Sanchez et al., 1997). Anti-tubulin antibodies were purchased from
Amersham (anti a -tubulin) or from Sigma (anti a -tubulin, DM 1A,
and anti b -tubulin, TUB 2.1). The antibody against acetylated a -
tubulin (6-11B-1) was kindly provided by Dr P. Gordon-Weeks and
the anti-GST antibody by Dr S. Goodbourn. Horseradish peroxidase-
conjugated secondary antibodies against rabbit IgG were obtained
from Amersham (UK) or from Dako (UK), and peroxidase-
conjugated antibody against mouse IgG was purchased from Sigma.
FITC-conjugated anti-mouse IgG and streptavidin, biotinylated anti-
rabbit and anti-mouse IgG, TMRITC-conjugated streptavidin and
mounting medium (Vectorshield) were obtained from Vector
Laboratories (UK).
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Cell culture and synchronisation
Mouse NIH 3T3 fibroblasts and monkey COS-7 cells were maintained
in DMEM containing 10% foetal bovine serum and 100 units/ml of
streptomycin and penicillin. Bovine mammary epithelial cells were
grown in the same medium with 5 m g/ml insulin and 50 m g/ml
hygromycin B. HeLa-S3 cells were grown in spinner cultures in RPMI
medium containing 10% foetal bovine serum and 100 units/ml of
streptomycin and penicillin. For cell synchronisation, COS-7 cells
were treated in the following way to obtain cell populations enriched
in cells in different stages of the cell cycle: cells in G0, serum
starvation (0.1% FCS) for 48 hours; cells in G1, stimulation of serum-
starved cells with 20% FCS for 5 hours; cells in S and G2 phases, pre-
synchronisation with 2 mM thymidine, release for 8 hours (DMEM,
10% FCS), aphidicolin arrest and release for different periods of time;
cells in mitosis, pre-synchronisation with 2 mM thymidine, release for
8 hours, arrest with nocodazole (0.4 m g/ml), mitotic shake-off and
release for different periods of time.
Cell fractionation experiments
HeLa-S3 cells were grown in spinner culture to a density of 3-5· 105
cells per ml, collected by centrifugation and washed in PBS. All
subsequent steps were performed at 4°C. The cells were subjected to
hypotonic lysis according to the method described by Vallee and
Collins (1986). Cells were resuspended in 10 times the packed cell
volume of swelling solution containing 10 mM Pipes buffer pH 6.9,
1 mM EGTA, 1 mM MgSO4 and protease inhibitors (CompleteTM
protease inhibitor tablets, Boehringer, and 0.4 mM PMSF) and
allowed to swell for 5 minutes. The volume of the medium was then
reduced to twice the packed cell volume, and the cells were lysed by
about 20 strokes in a Teflon-glass Potter homogeniser under
microscopical control. After lysis, 1 M Pipes, pH 6.9, was added to
make up the buffer concentration to 100 mM Pipes, 1 mM EGTA and
1 mM MgSO4 (PEM buffer). The particulate subcellular fractions
were obtained by the following subsequent centrifugation steps: 10
minutes at 600 g (nuclear fraction), 15 minutes at 20,000 g
(mitochondrial fraction) and 40 minutes at 150,000 g (ribosomal
fraction) in a TL-100 benchtop ultracentrifuge. To reduce cross-
contamination, the particulate fractions were resuspended and re-
centrifuged through a cushion of 10% sucrose in PEM buffer. The
protein concentration of each fraction was estimated using the
Bradford assay (Sigma) and bovine serum albumin as standard
protein.
Gel filtration of the postribosomal supernatant (S-100) was
performed on a Superose-6 HR10/30 column (Pharmacia) using a
BioLogic chromatography system (BioRad) at 4°C. About 10 mg of
S-100 protein were separated in a buffer containing 10 mM Hepes,
pH 7.2, 50 mM b -glycerophosphate, 2 mM MgCl2 and 0.5 mM each
of EDTA, EGTA, DTT and PMSF, at a flow rate of 0.4 ml/minute,
and 0.5 ml fractions were collected. For analysis of the distribution
of P23 and tubulin, the fractions were ethanol-precipitated overnight
at - 20°C, the protein pellets were dissolved in SDS-sample buffer
and equal portions were analysed by SDS-gel electrophoresis and
western blotting. For comparison, 50 m g of purified recombinant P23
were run separately. For calibration of the column, the elution
positions of the following molecular mass markers were determined
in separate runs: Blue Dextran (2,000 kDa), thyroglobulin (330 kDa),
b -amylase (200 kDa), alcohol dehydrogenase (150 kDa), bovine
serum albumin (68 kDa), carbonic anhydrase (29 kDa) and
cytochrome c (12.4 kDa).
For coimmunoprecipitation, the postmitochondrial fraction of HeLa
cells (1 mg of total protein) was incubated for 3 hours at room
temperature with an anti a -tubulin antibody (Amersham) crosslinked
to protein A-Sepharose beads (ImmunoPure kit, Pierce). Protein A-
Sepharose beads loaded with control antibodies (rabbit pre-immune
serum, Sigma) were incubated in the same way. The beads were
washed in TBS containing 0.5 M NaCl, and the bound material was
analysed by two-dimensional electrophoresis and subsequent western
blotting for the presence of P23. The 2D-electrophoresis was
performed according to the O’Farrell method using ampholines
(Sigma) ranging from pH 2.5 to 7. The part of the first dimension
corresponding to pH 3-5 was cut out and subjected to SDS-gel
electrophoresis in the second dimension. The presence of P23 protein
was verified by western blotting.
SDS-gel electrophoresis and western blotting
SDS-gel electrophoresis of proteins was performed using the Laemmli
system. Analysis of P23 protein was performed in 12% or 15%
polyacrylamide gels. For western blotting, the proteins were
transferred to Immobilon-P membranes using a semi-dry apparatus
and incubated with the corresponding primary antibodies, which were
then labelled with peroxidase-conjugated secondary antibodies and
detected using the ECL system (Amersham). For quantification, the
signals on X-ray films were scanned and quantified using a Personal
Densitometer SI and the ImageQuant software program (Molecular
Dynamics).
For comparison of the amount of acetylated and total a -tubulin in
MAC cells, the cells were grown to near-confluency, washed with PBS
and scraped directly into SDS-sample buffer containing 2% SDS, 100
mM Tris-HCl, pH 6.8, 10% glycerol, 50 mM DTT and 0.2 mM PMSF
(Bulinski et al., 1988) and boiled immediately. Equal volumes of cell
lysates were analysed by SDS-electrophoresis and western blotting,
and the signals were quantified as described before. For a loading
control, the blots were probed with an affinity-purified antibody
against the a -subunit of translation initiation factor eIF-2 (Bommer et
al., 1988).
Immunofluorescence staining
Cells were seeded in a multi-chamber slide at an initial density of 1-
5· 104 cells/cm2, grown for another 2 or 3 days and subjected to pre-
treatment as required for the experiment. Double-
immunofluorescence experiments were performed as follows. Cells
were washed with pre-warmed PBS, fixed with 3.7% glutaraldehyde
in PBS for 15 minutes, rinsed briefly in PBS at room temperature and
extracted with 1% Triton X-100 for another 15 minutes. The cells
were then permeabilised with methanol at - 20°C overnight. To
prevent the potential generation of background fluorescence by non-
specific absorption of immunoglobulins, the cells were incubated with
0.5% BSA in PBS. The cells were stained for detection of P23 with
the affinity-purified antipeptide antibody (P2), and with a biotinylated
anti-rabbit antibody, which was then decorated with TMRITC-
labelled streptavidin. The primary antibody showed a very low
background staining, as seen in control experiments where the
antibody was pre-incubated with either the peptide or purified
recombinant P23. In bovine cells, this antibody produced a signal only
when ectopically expressed murine P23 was present, which is an
additional proof of its specificity. In other control experiments, normal
rabbit serum (Sigma) was used instead of the anti-P23 antibody, using
an equivalent dilution of immunoglobulin. For visualisation of
microtubules, the cells were subsequently stained with a monoclonal
anti-a -tubulin antibody (Sigma) and with an FITC-conjugated anti-
mouse IgG as secondary antibody. An unrelated mouse IgG1
monoclonal antibody (CRA3 antibody to HIV gp120) was used as a
negative control in assays for anti-tubulin. All negative control assays
established the low level of background fluorescence in the fixed and
permeabilised cells with all fixation protocols.
Single staining experiments were performed with mouse
monoclonal antibodies against either human P23 or a -tubulin
(Amersham) using the following protocol. Cells were washed with
pre-warmed 0.1 M Pipes buffer, pH 6.9, fixed with 3.7% formaldehyde
in PBS for 45 minutes, rinsed briefly in PBS at room temperature,
extracted with 0.5% Triton X-100 for another 15 minutes and washed
three times in PBS. After pre-incubation for 15 minutes in 0.5% BSA
in PBS, cells were incubated with the primary antibody for 1 hour and
with biotinylated anti-mouse IgG and FITC-conjugated streptavidin
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for 30 minutes each, with three 5 minute washes in PBS containing
0.5% BSA after each incubation. The specificity of the staining
procedure was established either by omitting the primary antibody,
which yielded only an extremely low background staining, or by
staining with an unrelated monoclonal antibody, against the human
La-antigen (kindly provided by Dr I. Jeffrey), which displayed an
exclusively nuclear staining under these conditions.
Microscopy was performed with a Zeiss confocal laser scanning
microscope, type LSM-4, equipped with an 63/1.4 objective. For
consistent fluorescence evaluation and measurement, the photo-
multiplier, filter and laser power settings were adjusted to give an
image grey-scale intensity of less than 10 for negative control assays
and approximately 200 for maximal positive measurements (full scale
0-255). Consistent photo-multiplier settings were maintained
throughout a single series of experiments. The signal for P23 staining
was usually considerably lower than that for tubulin. In order to
maintain the full structural information, the P23 signal was enhanced
for the display in Fig. 2. For quantitative evaluation of microtubule
density per cell, the microtubule fluorescence signal and the cell area
were integrated using the LSM-4 computer program. The microtubule
density was then calculated as fluorescence signal intensity divided
by the cell area and displayed as arbitrary units. The values for relative
mouse P23 expression levels were obtained in the same way from the
signal of P23 staining. The correlation between P23 expression and
microtubule density per cell was tested by statistical analysis using a
simple linear regression model. The data was transformed to
logarithmic scale to fit the normal distribution assumption.
Protein interaction experiments
Proteins interacting with GST-P23 were investigated as follows. HeLa
cell extract (100 m g total protein) was incubated for 2 hours at room
temperature with 4 m g of GST-P23. The GST-P23 complexes were
bound to glutathione-agarose beads (30 m l beads) in a buffer
containing 10 mM Tris-HCl, pH 7.15, 150 mM NaCl, and 1 mM each
of EDTA, EGTA, PMSF and benzamidine. The beads were collected
by centrifugation and washed with 5 ml of the same buffer containing
0.5 M NaCl. Bound proteins were analysed by SDS-gel
electrophoresis and subsequent western blotting using monoclonal
antibodies against a - and b -tubulin (Sigma).
To demonstrate the binding of P23 to microtubules, taxol-stabilised
microtubules were prepared from rat brain according to the method
described by Vallee (1986). Microtubules (30 m l) were mixed with
purified proteins (1 m g each) as indicated in the figures and incubated
for 15 minutes at 37°C in 50 m l PEM buffer containing 0.1 mM ATP
and 20 m M taxol (Sigma). The microtubules were collected by
centrifugation for 5 minutes at 6,500 rpm in a microfuge, the pellet
was washed twice in 1 ml of the same buffer and centrifuged each
time under the same conditions. The pellets were denatured in SDS-
sample buffer in a total volume of 100 m l, and 20 m l of the sample
were subjected to SDS-gel electrophoresis and western blot analysis.
For comparison, 50 ng of each protein used in the assay were analysed
in parallel.
Expression of P23 in eukaryotic cells
The mouse P23 coding region was subcloned from the plasmid pT7.7-
P23 into the eukaryotic expression vector pcDNA-3 (Invitrogen)
under the control of the CMV promoter, downstream of the EcoRI
site. The resulting plasmid pcDNA-3/P23 was used for transient
expression of mouse P23 in COS-7 cells and for the establishment of
stable expressing cell lines. Transfection was performed using
Lipofectamine (Life Technologies), and the expression was verified
by western blotting. To establish stable expressing cell lines, bovine
mammary epithelial cells (Huynh et al., 1991) were seeded at a
density of 5 · 105 cells per 100 mm dish. On the following day, the
cells were transfected with the pcDNA-3/P23 plasmid or with the
empty vector for control transfections. 10 m g of plasmid DNA was
diluted into 0.25 ml of DMEM and mixed with a equal volume of
Lipofectamine (20 m g of lipid in 0.25 ml DMEM). The mix was
vortexed for 10 seconds, and the complexes were allowed to form for
30 minutes at room temperature. The volume was increased to 4 ml
with DMEM and the lipid-DNA mixture was applied to the cells and
allowed to incubate for 16-20 hours at 37°C. The cells were then
cultured for another 24 hours in fresh medium containing 10% FCS
and 5 m g/ml insulin. Subsequently, the cells were selected in the same
medium containing 50 m g/ml hygromycin B. Resistant colonies were
isolated after 14 days. Mouse P23 expression was assessed by western
blotting. FACS scan analysis was performed in a Becton-Dickinson
fluorescence-activated cell sorter after propidium iodide staining of
cells according to standard procedures.
RESULTS
P23 is a cytoplasmic protein that occurs in higher
molecular mass complexes and may be found in
association with tubulin
To gain insight into the functional importance of P23, we
studied its intracellular distribution. Subcellular fractionation
experiments revealed that P23 is a cytoplasmic protein that is
not associated with the nuclear, mitochondrial or ribosomal
fractions (Fig. 1A). This result was confirmed by centrifugation
of postnuclear supernatants in the self-generating gradient
material OptiPrepTM (provided by Nycomed Pharma AS,
Oslo), where P23 did not focus with any of the classical cell
organelle fractions (B. Sawitzki and U.-A. Bommer,
unpublished observation). To investigate whether the
cytoplasmic P23 might be involved in higher molecular mass
complexes, we performed gel filtration experiments with a
HeLa cell postribosomal supernatant (S-100) on a Superose 6
column (Fig. 1B). The results demonstrate that P23 is eluted
over a fairly wide range of fractions starting significantly
earlier than the elution of the pure recombinant protein.
Calibration of the column showed that the P23-containing
fractions correspond to a molecular mass range from about 40
to 150 kDa, whereas pure recombinant P23 elutes at about 40-
60 kDa. This indicated that, in the cell, P23 occurs both free
and in at least one higher molecular mass complex of 100-150
kDa. In both NIH 3T3 (result not shown) and HeLa cell
extracts, the elution pattern of P23 is very similar and the
abundance of P23 is usually higher in the complexed form
compared to free P23. We also tested the distribution of tubulin
on the same western blots (Fig. 1B), and the results showed
that tubulin is present in all fractions from the void volume
down to about 100 kDa. Incidentally, the last 3-4 tubulin-
containing fractions, which are likely to represent dimeric
tubulin, do also contain the higher molecular mass complex of
P23. To investigate whether P23 might be associated with
tubulin, we performed coimmunoprecipitation studies. As none
of our anti-P23 antibodies is able to immunoprecipitate the
protein from cell extracts, we used an anti a -tubulin antibody
crosslinked to protein A-Sepharose beads. After incubation
with a postnuclear supernatant from HeLa cells, the affinity
resin was washed with TBS containing 0.5 M NaCl. In order
to eliminate the interference by the immunoglobulin light
chain, the adsorbed proteins were analysed for the presence of
P23 by two-dimensional electrophoresis and western blotting.
The result (Fig. 1C) shows that P23 can be precipitated with
anti-tubulin antibodies, whereas no precipitation was observed
with the control antibodies. However, the yield of P23
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recovered under these conditions was rather low, indicating
that only a proportion of P23 is associated with tubulin.
P23 associates with microtubules in a cell cycle-
dependent manner
To address the question of whether P23 might be associated
with microtubules, we studied its subcellular localisation in
COS cells by immunofluorescence confocal microscopy. Our
staining protocol employed fixation with formaldehyde or
glutaraldehyde, followed by extraction with Triton X-100 to
remove the excess of unbound P23 protein. For double-
immunostaining, an affinity-purified rabbit antipeptide
antibody was used to localise P23, and a mouse monoclonal
antibody against a -tubulin for microtubule staining. The
affinity-purified antibody was characterised for its specificity,
and control experiments verified that no cross-reactivity
occurred under the chosen conditions (see Materials and
methods). For single-staining, a monoclonal antibody against
human P23 was applied in parallel experiments with
microtubule staining. We obtained essentially the same results
with both antibodies, and examples are shown in Fig. 2.
Our initial immunolocalisation experiments revealed a
cytoskeletal organisation of P23, similar to the one of
microtubules. We asked whether the microtubule-association
of P23 may change during the cell cycle. COS cells were
synchronised and stained as described in Materials and
methods, and Fig. 2 shows images for microtubule and P23
staining of representative cells in different cell cycle phases.
The following observations have been made. (1) In serum-
starved cells, the P23 staining displayed a very faint, punctate
pattern with a scarce distribution of individual signals and a
higher number of signals in the perinuclear area (Fig. 2b). The
overall signal was considerably weaker than in cycling cells,
and quantification of the fluorescence intensity per cell
revealed an increase of about 3.5-fold in the microtubule-
associated P23 signal upon entry of cells into the cell cycle
(results not shown). (2) A clear colocalisation of P23 with
microtubules was observed in the G1, S and G2 phases of the
cell cycle (Fig. 2c-h). The signal intensity for P23 staining was
considerably weaker compared to the tubulin signal, and it is
enhanced in the displayed images in order to maintain the full
structural information. When displayed at higher
magnification, the P23 signal often appeared to be
discontinuous along microtubules (not shown). (3) In early
mitotic cells, we consistently observed P23 staining associated
with metaphase spindles, as shown here with two different
antibodies (Fig. 2k,m). However, from anaphase onwards, P23
staining was no longer microtubule-associated, and it appeared
to be rather diffuse (Fig. 2o). In early postmitotic cells, the
microtubule staining with the P23 antibody was very poor,
similar to the picture seen in serum-starved cells (result not
shown). Thus, the results presented in Fig. 2 provide clear
Fig. 1. P23 is a cytoplasmic protein that is found in association with
tubulin. (A) P23 is a cytoplasmic protein. Subcellular fractions from
HeLa-S3 cells were prepared as described in Materials and methods.
40 m g protein of each of the nuclear (lane 1), mitochondrial (lane 2),
ribosomal (lane 3) and postribosomal (lane 4) fractions were
subjected to SDS-electrophoresis and subsequent western blotting.
The Coomassie Blue-stained gel after electrotransfer is shown at the
top, and below is the western blot probed with an anti-P23 antibody.
(B) P23 occurs in a high molecular-mass complex. The
postribosomal supernatant from HeLa-S3 cells (10 mg protein) was
subjected to gel filtration on a Superose-6 column as described in
Materials and methods. The fractions were analysed by SDS
electrophoresis and western blotting for the presence of a -tubulin
and P23 as indicated. Arrows at the top indicate the elution positions
of molecular mass marker proteins from the column. In a parallel
run, the elution position of purified recombinant P23 was analysed
(bottom). The fraction numbers beginning from the void volume are
given below the figure. (C) P23 can be co-immunoprecipitated with
tubulin antibodies. A HeLa cell extract was incubated with an anti a -
tubulin antibody coupled to protein A-Sepharose, and the bound
material was analysed by two-dimensional gel electrophoresis and
western blotting using an anti-P23 antibody. The western blot of the
relevant part is shown here. A, control experiment using a pre-
immune serum for immunoprecipitation; B, immunoprecipitation
with anti a -tubulin antibodies. Arrows indicate the position of P23
protein.
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evidence for a cell cycle-dependent interaction of P23 with
microtubules in vivo. P23 is found in association with
microtubules during G1, S, G2 and early M phases of the cell
cycle, whereas no such association could be observed in the
late mitotic phases and in serum-starved cells.
P23 has properties a tubulin binding protein
To examine the ability of P23 to bind to tubulin in vitro, we
constructed a bacterial expression plasmid for a GST-P23
fusion protein. The fusion protein and a GST control protein
were expressed and purified from E. coli. The purified proteins
were incubated with a postnuclear supernatant from HeLa cells
and bound to glutathione-agarose beads. The beads were
washed and bound proteins were analysed for the presence of
tubulin by western blotting. The results shown in Fig. 3A
demonstrated that GST-P23 is able to interact with a - and b -
tubulin from a HeLa cell extract. Neither protein bound to the
GST control protein, and we did not observe binding of actin
to GST-P23 under these conditions (result not shown).
We then examined the ability of P23 to bind to polymerised
microtubules. Taxol-stabilised microtubules were incubated
with purified recombinant P23 proteins from different species
(mouse, human and yeast) and with GST as a control. The
microtubule pellets were collected by centrifugation, washed
and analysed for the presence of P23 by western blotting using
the appropriate antibodies. The results (Fig. 3B) show that the
recombinant P23 protein preparations from different species
bound to rat brain microtubules, whereas no binding was
observed in the case of the GST control protein. No P23 protein
was pelleted in the absence of microtubules (result not shown).
We then asked the question whether the P23 protein contains
a specific domain which might be responsible for tubulin
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Fig. 2. P23 colocalises with microtubules in a cell cycle-dependent manner. COS-7 cells were grown on multi-chamber slides, and to obtain
partially synchronised cell populations, cells were treated as described in Materials and methods. Cells were then fixed, extracted with Triton
X-100 and stained separately with an antibody against a -tubulin (a,c,e,l) or with the monoclonal anti-P23 antibody (b,d,f,m). Images of cells
that were double-stained with the anti-tubulin antibody and the affinity-purified rabbit polyclonal antibody against an internal peptide of P23
are shown in g, h, i, k, n, o. Details of the procedures and antibodies are given in Materials and methods. Immunofluorescence images were
obtained by confocal microscopy and are separately displayed for tubulin staining (a,c,e,g,i,l,n) and for P23 staining (b,d,f,h,k,m,o). Note that
the P23 signal is enhanced compared to the tubulin signal. Representative examples of cells in the following cell cycle phases are shown: G0
(a,b), G1 (c,d), S (e,f), G2 (g,h), early mitosis (i,k,l,m) and late mitosis (n,o).
1263P23 is a tubulin binding protein
binding. As both tubulin (pI 4.8/5.3) and P23 (pI 4.5) are acidic
proteins, any non-specific binding via electrostatic interactions
is unlikely. However, plotting the distribution of charged amino
acids within the P23 sequence revealed a polarisation of the
molecule into two acidic regions (domain 1, amino acids 1-78,
and domain 3, amino acids 124-172) separated by a basic
region (amino acids 79-123, referred to as domain 2) (Fig. 4A).
A search for sequence similarities to the basic domain of P23
revealed similarity to part of the tubulin binding domain of the
microtubule-associated protein MAP-1B (Fig. 4A). The
sequence of the basic domain is highly conserved among the
known mammalian P23 sequences. Although the overall
identity with the corresponding MAP-1B sequence is only 33%
(similarity 46%), there is a remarkable similarity in the
distribution of charged amino acids, particularly of lysine and
glutamic acid residues. To investigate whether the basic region
represents the tubulin binding domain of P23, we generated a
set of GST-P23 mutant protein constructs truncated in the three
domains of the P23 protein (Fig. 4B). These mutant proteins
were expressed, purified from bacteria, and verified by western
blotting using antipeptide antibodies directed against different
parts of the P23 sequence (results not shown). The ability of
these proteins to bind tubulin was tested in the assays described
above. The binding assay using HeLa cell extract as a source
of tubulin revealed that only those GST-P23 constructs bearing
the basic domain were able to bind a - and b -tubulin (Fig. 4C).
Moreover, only these constructs bound to taxol-stabilised
microtubules (Fig. 4D). We concluded that this domain of P23
is both necessary and sufficient to confer tubulin binding
activity.
Overexpression of P23 leads to alterations in cell
growth and morphology
In order to investigate whether alteration of the intracellular
P23 levels may affect the microtubular cytoskeleton and cell
growth, we performed overexpression experiments. We
subcloned the coding region of the mouse P23 cDNA into the
pcDNA-3 vector under the control of the CMV promoter. We
chose bovine mammary epithelial cells (MAC cells; Huynh et
al., 1991) for these experiments, which have the advantage that
the ectopically expressed mouse P23 can be distinguished from
the endogenous bovine P23 by a specific antipeptide antibody
(Fig. 5A). We transfected two lines of these cells: one line, here
referred to as MAC-A, had been immortalised by the large T
antigen, whereas the second line (MAC-B) represents a
spontaneously immortalised cell line. Both lines were
transfected with the P23 expression vector and with the empty
vector for control. Five mouse P23-expressing cell lines were
cloned from each parental cell line after selection on
hygromycin B. Two clones with high P23 expression levels,
referred to as MAC-A/23-1 and MAC-B/23-5, and the
corresponding vector control cell lines, MAC-A and MAC-B,
were chosen to perform the experiments below. By western
blotting, the average P23 levels in these two cell lines were
estimated to be about twofold higher than the endogenous P23
levels of the control cell lines (Fig. 5A). This indicates that
much higher expression levels cannot be achieved in stable
expressing cell lines.
P23-overexpressing cells displayed a much slower growth
rate compared to their parental counterparts (Fig. 5B).
Calculation of the growth parameters from these curves
showed that upon P23 overexpression, the doubling time
increased threefold in MAC-A cells and twofold in MAC-B
cells. Other clones which expressed lower levels of murine P23
displayed a more moderate reduction in the growth rate (results
not shown), indicating that the growth rate is inversely related
to the level of expression of murine P23. Increase in P23 levels
also resulted in alterations of cell morphology (Fig. 5Ca-d). In
both cell lines investigated here, P23 overexpression led the
cells to adopt a very elongated cell shape (b,d), clearly different
from the morphology of the parental cells (a,c). In less
confluent cultures, we also observed a higher variability of cell
shape and the tendency to an increased cell size, the latter being
confirmed by FACS scan analysis (Fig. 5D). The FACS scan
investigations also showed that a higher percentage of cells is
in the G2/M phase of the cell cycle (Fig. 5D). This result
indicated that a distortion of the cell division process could be
involved in causing the growth inhibitory effect.
Overexpression of P23 affects the microtubular
cytoskeleton
The observed morphological alterations in P23-overexpressing
cells indicated that changes in the microtubular cytoskeleton
might be involved. Therefore, we investigated whether
elevation of P23 levels affected features of the microtubular
network. Microtubules in P23-overexpressing cells (MAC-
B/23-5) and control cells (MAC-B) were visualised by
immunofluorescence staining and confocal microscopy, and
representative images are shown in Fig. 6Aa,c. Comparison of
the microtubule patterns between the two cell lines showed
that, in the P23-overexpressing cells, the microtubules were
preferentially arranged in parallel rather than in a radial
Fig. 3. Interaction of P23 with tubulin and microtubules. (A) Tubulin
binds to a GST-P23 fusion protein. Purified GST and GST-P23
proteins were incubated with a HeLa cell postnuclear supernatant
and bound to glutathione-Sepharose beads. Bound proteins were
analysed by SDS-gel electrophoresis and western blotting.
Immunodetection was performed with anti a -tubulin and b -tubulin
antibodies as indicated. In the first lane, 50 m g of total HeLa cell
extract was loaded as a control. (B) Recombinant P23 binds to taxol-
stabilised microtubules in vitro. Taxol-stabilised microtubules were
incubated with the following purified recombinant proteins as
indicated: GST and P23 from mouse, humans and yeast
(Saccharomyces cerevisiae). The microtubules were collected by
centrifugation, washed and analysed by SDS-gel electrophoresis and
western blotting. The upper panel shows a western blot of the
purified proteins before binding, and the lower panel shows a western
blot of the microtubule pellets. Antibodies used for probing of both
blots are indicated at the top. Note that the mobility of the yeast P23
is slightly reduced compared to the mammalian P23.
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manner, with a fairly dense packaging, similar to microtubule
bundling.
For quantitative analysis of microtubule density, MAC-
B/23-5 cells were double-stained for microtubules and murine
P23. The images of individual cells were assessed for the total
fluorescence intensities of microtubules and P23, respectively.
The results shown in Fig. 6B demonstrate that, on average,
MAC-B/23-5 cells displayed a 30-40% higher density of
microtubules compared to the parental cells. To establish a
correlation between microtubule density and P23 levels, cells
were grouped into low, medium and high ‘expressers’, and the
average microtubule densities of the different groups were
plotted in Fig. 6B. Statistical analysis of the complete data set
using a linear regression model proved that the increase in
microtubule density related positively to the increase of mouse
P23 expression levels (y=0.29x–2.67; ANOVA, F1,22=14.02,
P<0.001; r2=0.389). The graphical display demonstrating this
correlation is shown in the lower panel.
To determine whether elevation of P23 levels affected
microtubule stability, we investigated the protection of
microtubules in MAC-B and MAC-B/23-5 cells against
nocodazole-induced destabilisation. After treatment with
nocodazole, the cells were subjected to microtubule-staining
and confocal microscopy. Representative images are shown
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Fig. 4. Characterisation of the tubulin binding domain of P23. (A) P23
contains a basic domain similar to part of the tubulin binding region of MAP-
1B. The histogram shows the distribution of basic and acidic amino acids
within the P23 sequence. The sequence comparison below demonstrates the
conservation of the basic domain among mammalian P23 sequences and its
similarity to a partial sequence within the tubulin binding region of human
MAP-1B (GenBank accession number: L 06237). Identical residues are
boxed. Amino acids in the human/rabbit P23 sequence which differ from the
mouse/rat sequences (positions 93 and 107) are shown in italic. GenBank
accession numbers of P23 sequences are: X 06407 (mouse), U 20525 (rat), X
16064 (human) and Z 46805 (rabbit). (B) Schematic representation of the
truncated GST-P23 fusion proteins. Bars represent the part of the P23 amino
acid sequence present in the mutant protein. The filled portion of the bar
highlights the putative tubulin binding domain. The hatched bar indicates the
C-terminal end of the GST portion. (C) Interaction of mutant GST-P23 fusion
proteins with tubulin. The mutant proteins represented in B were incubated with HeLa cell extract and bound to glutathione-agarose beads. The
beads were washed and analysed for binding of a - and b -tubulin by SDS-gel electrophoresis and western blotting. The different GST fusion
proteins are indicated in the individual lanes. (D) Binding of mutant GST-P23 fusion proteins to taxol-stabilised microtubules. Microtubules
were incubated in the presence of the mutant GST-P23 fusion proteins as indicated in the individual lanes. The microtubules were collected by
centrifugation, washed and analysed by SDS-gel electrophoresis and western blotting. Upper panel, probing of the GST-fusion proteins before
binding; lower panel, probing of microtubule-bound material. The blots were probed with anti-GST antibodies.
A
D
B
C
1265P23 is a tubulin binding protein
Fig. 5. Overexpression of P23 in bovine MAC-T cells results in
alterations of cell growth and morphology. The following mouse
P23-expressing cell lines were established from bovine
mammary epithelial cells as described in the text: MAC-A and
MAC-B (vector control cells) and MAC-A/23-1 and MAC-B/23-5 (mouse P23-expressing cells). (A) Assessment of P23 expression levels. Cell extracts (8
m g protein each) were analysed for P23 protein levels by western blotting: MAC-B (lane 1), MAC-B/23-5 (lane 2), MAC-A (lane 3) and MAC-A/23-1 (lane
4). The western blots were probed with the indicated antibodies. The antibody against recombinant mouse P23 protein detects both the endogenous and the
murine P23, whereas the anti-peptide antibody specifically detects the expressed mouse protein. The graph below shows a quantitative analysis of the P23
levels from the blot developed with the antibody against the complete P23 protein. The signals were quantified and the intensity of the P23 signal was
normalised against the corresponding actin signal. The relative P23 protein levels were plotted setting the value for the MAC-A cell line as 100%. Open bars,
control cell lines; filled bars, P23-overexpressing lines. (B) Elevation of P23 levels results in a slow-growth phenotype. The graph shows growth curves of all
four cell lines. Cells were seeded at a density of 3· 104 cells per well in 24-well plates, grown for up to 8 days and counted daily in a haemocytometer. Open
symbols: control cells, MAC-A (circles) and MAC-B (squares); filled symbols: cell lines expressing murine P23, MAC-A/23-1 (circles) and MAC-B/23-5
(squares). A representative of three independent experiments is shown. (C) P23 overexpression results in morphological alterations. Phase-contrast
microphotographs of control cells and of mouse P23-expressing cell lines are shown. a, MAC-A cells; b, MAC-A/23-1 cells; c, MAC-B cells; d, MAC-B/23-
5 cells. Bar, 100 m m. (D) FACS scan analysis of MAC-A and MAC-B cell lines. Left, the distribution of cells between cell cycle phases (open bars, vector
control cells; filled bars, P23-overexpressing cells). Right, the cell size distribution of the same cell lines (clear area, vector control cells; shaded area, P23-
overexpressing cells).
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Fig. 6. P23 overexpression leads to
alterations in microtubule arrangement,
mass and stability.
(A) Immunofluorescence images of
microtubules in P23-overexpressing
cells. Control cells MAC-B (a,b) and
P23-overexpressing cells MAC-B/23-5
(c,d) were grown on multi-chamber
slides. The cells were fixed, extracted
with 1% Triton X-100, stained for
visualisation of microtubules and
subjected to fluorescence confocal
microscopy. Before fixation and
immunostaining, the cells in b and d
were subjected to microtubule-
destabilisation by treatment with 4 m g/ml
nocodazole for 1 hour. (B) Quantitative
analysis of the microtubule density in
MAC-B/23-5 cells. Cells were fixed, extracted with Triton X-100, double-stained for
visualisation of microtubules and of murine P23 and subjected to confocal microscopy. The
fluorescence intensities for both signals and the cell area were integrated using the LSM-4
software program, and the microtubule density for 25 cells was calculated as described in
Materials and methods. The upper graph shows the average microtubule density for MAC-B
cells (grey bar) and for MAC-B/23-5 cells (black bar) on the left. On the right, the increase in
microtubule density with increasing mouse P23 expression levels in MAC-B/23-5 cells is
demonstrated. Cells were divided into three groups with low, medium and high P23 expression,
and the average P23 expression levels (open bars) and microtubule densities (black bars) are
displayed for each group. The graph below shows the linear regression analysis demonstrating
the relationship between the microtubule density and mouse P23 expression level in MAC-B/
23-5 cells on a logarithmic scale basis. Note that the antipeptide antibody used for visualisation
of P23 detects only the expressed murine P23 (Fig. 5A). (C) Nocodazole-destabilisation of
microtubules. MAC-B cells and MAC-B/23-5 cells were either left untreated or were treated with nocodazole (4 m g/ml for 1 hour) and subsequently stained
for visualisation of microtubules as in Ab,d. The intensity of the microtubule fluorescence signal for 20 cells per cell line and treatment was quantified and
the average values were calculated. The values were normalised to compare the relative microtubule mass of MAC-B/23-5 cells (black bars) with that of
MAC-B cells (open bars) for each treatment separately. Note that the absolute fluorescence intensity was much lower in nocodazole-treated cells. (D) Levels
of acetylated tubulin in MAC-B cells versus MAC-B/23-5 cells. Both cell lines were grown to near-confluency on 10 cm dishes and lysed into SDS-
containing buffer as described in the experimental section. Equal volumes of cell extracts were analysed by SDS-electrophoresis and western blotting. The
blots were probed for acetylated a -tubulin (top), for a -tubulin (middle) and with an unrelated antibody (bottom) as a loading control. As a positive control
for the acetylation reaction, MAC-B cells were treated overnight with 10 m M taxol (lane 1). Untreated MAC-B cells (lane 2) and MAC-B/23-5 cells (lane 3)
were analysed using the indicated antibodies. The graphs below show the relative levels for a -tubulin and for acetylated a -tubulin in MAC-B cells (open
bars) and MAC-B/23-5 cells (black bars) obtained from scanning the signals in lanes 2 and 3, and after correction for the loading control signals.
Nocodazole 
0
50
100
150
200
250
300
No treatment
0
20
40
60
80
100
120
140
160
A
D
B
C
1267P23 is a tubulin binding protein
in Fig. 6Ab,d. Quantitative assessment of the microtubule
mass from the overall microtubule fluorescence of 20
nocodazole-treated cells and an equal number of untreated
cells per cell line revealed that in P23-overexpressing cells,
the microtubules were considerably protected against
depolymerisation by nocodazole (Fig. 6C). In another assay,
we assessed the relative amount of acetylated a -tubulin in
MAC-B and MAC-B/23-5 cells by means of western blotting
(Fig. 6D). The monoclonal antibody 6-11B-1 specifically
detects acetylated a -tubulin (LeDizet and Piperno, 1991) and
has been used before to quantify stable microtubules
(Bulinski et al., 1988). In a control experiment, MAC-B cells
were treated with the microtubule-stabilising agent taxol,
which resulted in a vast increase in the western blot signal
from the antibody 6-11B-1 (lane 1). In contrast, the signal
obtained with this antibody in untreated cells was very low
compared to that for unmodified a -tubulin (lanes 2 and 3).
However, in each experiment, the signal was considerably
higher in MAC-B/23-5 cells compared to the control MAC-
B cells. Quantification of the blots revealed that the amount
of stable microtubules was about 2.5-fold higher in the MAC-
B/23-5 cell line compared to the control cells, and the total
tubulin content was increased by about 30%. This is in
remarkable agreement with the figures obtained by the
microtubule-destabilisation assay, when the microtubule
mass was estimated by confocal microscopy (cf. Fig. 6C).
Thus, the data presented in this section demonstrate that
elevation of intracellular P23 levels results in microtubule
stabilisation.
DISCUSSION
P23 binds to tubulin and associates with
microtubules during specific phases of the cell
cycle
We investigated the intracellular distribution of P23 by cell
fractionation and immunofluorescence microscopy. Our
results demonstrated that P23 is a cytoplasmic protein which
was not found in association with any organelles. In a gel
filtration experiment, we showed that P23 occurs both free
and in complexes of up to 150 kDa. As the complexed form
was detected in the same fractions as dimeric tubulin, we
investigated whether P23 can be immunoprecipitated by anti-
tubulin antibodies, and we showed that a fraction of P23 is
indeed precipitated. Although, our protocol was not suitable
for obtaining quantitative data, we estimated that only about
10% of the total P23 protein was bound to the beads,
indicating that the interaction is relatively weak and/or that
only a small proportion of P23 is actually bound to tubulin.
The latter possibility is in line with observations from the
immunostaining experiments, as the excess of unbound P23
protein obscured the display of the microtubular cytoskeleton
with P23 antibodies when the Triton extraction step was
omitted from the immunostaining procedure (not shown).
The results of the immunofluorescence experiments
provided evidence for the association of P23 with
microtubules in vivo. The specificity of the immunostaining
reaction was established in various control experiments, and
we demonstrated the cell cycle-dependent colocalisation of
P23 with microtubules both with a mouse monoclonal
antibody and with an affinity-purified antipeptide antibody
from rabbit. Fixation with glutaraldehyde or with
formaldehyde yielded essentially the same results, whereas
methanol fixation was not suitable to stabilise the interaction
of P23 with microtubules sufficiently. We consistently
observed two types of structural organisation of P23 protein
in the cell, i.e. colocalisation with the microtubular network,
typically in G1, S and G2 phase cells (Fig. 2d,f,h), and a
punctate organisation with a scarce distribution of individual
signals in the cytoplasm, usually found in resting cells (Fig.
2b) and in early postmitotic cells (result not shown). Close
inspection of the latter types of images at a higher
magnification and at other sectioning settings of the confocal
microscope revealed that these ‘punctate’ signals are often
displayed as short string-like structures, which are likely to
represent residual microtubular localisation of P23. By z-
scanning, the apparent nuclear staining in these images could
also be resolved as residual staining of cytoskeletal structures
surrounding the nucleus. Although we did observe some
nuclear staining in individual cells (see e.g. Fig. 2f), this was
not related to specific cell cycle phases, but is more likely to
be due to incomplete removal of the unbound P23 during the
extraction, considering that the relatively small protein may
diffuse through the nuclear pore and may get trapped in the
nucleus during the procedure. In summary, the results of our
immunolocalisation studies showed that P23 is hardly found
on microtubules when cells are in the resting state; however,
it is present on microtubules during most phases of the cell
cycle, inclusive of the mitotic spindle during metaphase. The
observation that P23 is not bound to the spindle during the
later mitotic phases and to microtubules in early postmitotic
cells indicates that the microtubule-association of P23 is
down-regulated in mitosis, presumably during metaphase-
anaphase transition.
We investigated the ability of P23 to bind to tubulin by in
vitro experiments using GST-P23 fusion proteins. The results
of the binding studies (Figs 3A, 4C) clearly showed that P23
associates with dimeric tubulin both in cell extracts and in
vitro. We also demonstrated binding of purified recombinant
P23 to taxol-stabilised microtubules prepared from rat brain
in vitro (Figs 3B, 4D). We found that approximately 40% of
the input protein was bound to the microtubules under our
conditions (result not shown), which included two washings
of the microtubule pellet in a 30-fold excess of buffer each.
Identification of the tubulin binding domain of mammalian
P23 (Fig. 4) revealed that it represents a highly charged,
mainly basic region within an otherwise very acidic protein,
which shares similarity with part of the tubulin binding region
of MAP-1B (Fig. 4A). The tubulin binding domain is highly
conserved among the vertebrate P23 homologues but it does
not comprise one of the two ‘TCTP(P23) signatures’, which
were identified in the PROSITE database as areas highly
conserved between P23 sequences of all eukaryotic phyla.
Although there are differences between the putative tubulin
binding site of mammalian P23 and the corresponding
regions of yeast and plant P23, they all have the common
feature of being a highly charged, basic region of the protein,
with a conserved distribution of the charged amino acids.
Interestingly, nearly 90% of the charged amino acids within
this region are lysine and glutamic acid residues. The
predominance of lysine and glutamic acid residues is also a
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typical feature of the tubulin binding region in MAP-1B,
which contains reiterated KKEX motifs (Lien et al., 1994;
Noble et al., 1989). These motifs appear to be important for
the interaction with microtubules, in the case of both MAP-
1B (Noble et al., 1989) and of centromere binding proteins
(Jiang et al., 1993). It seems possible that the interaction of
P23 with tubulin has a similar basis.
Overexpression of P23 affects cell morphology and
the microtubular cytoskeleton
To investigate the potential of P23 to modulate the
microtubular cytoskeleton in vivo, we performed
overexpression experiments. We estimated the endogenous P23
level by western blotting to be about 0.1% (w/w) of the soluble
cellular protein, a range comparable to that of microtubule-
associated proteins (Barlow et al., 1994; Nguyen et al., 1997).
A twofold increase of the total P23 level in bovine mammary
epithelial cells resulted in an increase in the average cell size
(Fig. 5D) and in considerable morphological alterations (Fig.
5C). The former observation could be related to the larger
number of cells in the S and G2/M phases of the cell cycle (Fig.
5D), and the alterations of cell shape suggested that
rearrangements of the microtubular cytoskeleton may have
occurred. Visualisation of microtubules revealed that
significant rearrangements of the microtubular network had
indeed occurred (Fig. 6A), in particular a predominantly
parallel orientation of microtubules compared to the more
radial arrangement in the vector control cells. We frequently
observed arrays of densely packaged microtubules in the cell
extensions, which were reminiscent of microtubule bundles.
Another type of microtubule bundling, in the form of
circumferential whorls of microtubules, was observed in
individual cells with high P23 expression levels, e.g. in
transiently transfected COS-7 cells and in insect Sf9 cells
(results not shown).
Rearrangement and bundling of microtubules is frequently
observed in cells overexpressing microtubule-associated
proteins (Barlow et al., 1994; Takemura et al., 1992, 1995;
Umeyama et al., 1993; Weisshaar et al., 1992; reviewed by
Hirokawa, 1994; Maccioni and Cambiazo, 1995; Mandelkow
and Mandelkow, 1995). However, the individual MAPs differ
considerably in their efficiency to induce such microtubule
alterations (Barlow et al., 1994; Nguyen et al., 1997;
Takemura et al., 1992; Wang et al., 1996). The effect of MAPs
on the microtubular cytoskeleton is mainly attributed to their
microtubule-stabilising function, which has been
demonstrated both by in vitro assays (Gamblin et al., 1996;
Pryer et al., 1992; Vandecandelaere et al., 1996) and in
numerous overexpression studies (Lee and Rook, 1992;
Takemura et al., 1992; Nguyen et al., 1997; reviewed by
Hirokawa, 1994; McNally, 1996). Therefore, we asked
whether the observed microtubule rearrangements in P23-
overexpressing cells were related to increased microtubule
stability. To this end, we compared the microtubule stability
in MAC-B and MAC-B/23-5 cell lines (1) by estimating the
microtubule density per cell and the relative microtubule
mass by confocal microscopy, (2) by assessing the amount of
stabilised microtubules in a microtubule-destabilisation assay
and (3) by comparing the relative amount of total tubulin and
of stable microtubules by western blotting. The results of all
these investigations were in good agreement and showed that
the relative quantity of stable microtubules is about 2.5-fold
higher in the P23-overexpressing cell line compared to the
vector control cells and that the amount of total
microtubules/tubulin is about 30% higher. The effect of
increase in P23 on tubulin levels is likely to be secondary to
microtubule stabilisation, as tubulin synthesis is tightly
regulated in relation to the total microtubule mass of the cell.
We conclude from this data that P23 overexpression exerts a
net stabilising effect on microtubules. The dynamic
instability of microtubules results from the equilibrium of
four basic processes, i.e. polymerisation, depolymerisation,
catastrophe and rescue (reviewed by McNally, 1996). It
remains to be investigated which of these individual
processes is particularly affected by raising intracellular P23
levels. The microtubule stabilising effect of P23 observed in
vivo may also be indirect, resulting from P23 interfering with
processes that affect the overall microtubule stability, but are
primarily mediated by other proteins. The observed alteration
of cell morphology in the P23-overexpressing cells is likely
to be a result of the microtubule stabilising effect, as
microtubules are a major determinant for cell shape.
The results presented in this study show that P23 has
tubulin binding properties, that it is found in association with
tubulin or microtubules in vitro and in vivo, and that it exerts
a net stabilising effect on microtubules once it is
overexpressed. These observations, together with the
abundance of P23, indicate a relationship to microtubule-
associated proteins. However, P23 is certainly not a bona fide
MAP, as MAPs are about tenfold larger proteins whose
affinity to microtubules is considerably higher than that of
P23. In terms of its size, P23 is more related to the tubulin
binding protein stathmin/Op18, which was recently shown to
have microtubule-destabilising activity (reviewed by Lawler,
1998). It is well documented that stathmin/Op18 binds to
dimeric tubulin (Jourdain et al., 1997; Curmi et al., 1997),
and more recently it was reported that a subfraction of
stathmin can also be found at the mitotic spindle (Gavet et
al., 1998). P23 is therefore not unique in its ability to bind to
both tubulin and microtubules, although this property is
unusual among proteins interacting with tubulin/
microtubules. Several questions remain to be addressed in
further studies. (1) At present, we cannot resolve the question
of whether the P23-microtubule interaction might be
mediated by other proteins, as the microtubule preparations
used in this study were not free of MAPs. (2) It will be
necessary to investigate, by employing more specific assays,
whether P23 (overexpression) directly affects specific
determinants of microtubular dynamic instability or whether
it is involved in other processes, which may indirectly affect
the equilibrium of microtubule dynamics.
Effect of P23 overexpression on cell growth
Our overexpression experiments also showed that elevation of
intracellular P23 levels resulted in a considerable inhibition of
cell growth (Fig. 5B). Previous observations demonstrated that
P23 levels are positively related to cell growth. (1) The rate of
P23 synthesis is up-regulated very early after growth
stimulation of mammalian cells and is down-regulated in
quiescent cells (Thomas, 1986; Böhm et al., 1989) and in cells
under stress conditions (Bommer et al., 1994). (2) Immuno-
histochemical staining of whole mouse slices revealed that P23
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levels are particularly high in actively proliferating tissues,
such as skin and gut (R. Benndorf and U.-A. Bommer,
unpublished observation). (3) The plant homologue of P23 was
found to be highly expressed in proliferating tissues of pea
roots (Woo and Hawes, 1997) and in barley (K. Müller and W.
Rohde, personal communication), and similar observations
have been made in the polyp Hydra (L. Yan, K. Fei and M.P.
Sarras Jr., personal communication). These results are in line
with our findings from immunostaining experiments and from
western blots (not shown) demonstrating that P23 levels
increase about fourfold during the transition of cells from the
resting to the growing state. The demonstration that P23
overexpression leads to growth retardation does not necessarily
contradict the notion that P23 is positively involved in cell
growth. In the case of various other growth-promoting gene
products, both over- and underexpression often resulted in
growth retardation, or even cell death.
Overexpression of the microtubule-associated protein
MAP-4 has recently been shown to result in reduction of the
cell growth rate (Nguyen et al., 1997), apart from interfering
with intracellular vesicle transport (Bulinski et al., 1997). In
the case of P23, the results of our FACS scan analysis (Fig.
5D) indicated that overexpression may affect the progression
of cells through mitosis. A delay of cell division could be
explained simply by the microtubule stabilising effect of P23
inhibiting the onset of mitosis (Zhai et al., 1996). Another
explanation relates to the observed binding of P23 to the
mitotic spindle during metaphase. P23 might exert a specific
function during mitosis requiring precise regulation of its
spindle association, which may be affected by
overexpression. Other proteins that have been found in
association with the mitotic spindle include motor proteins
(recently reviewed by Hoyt and Geiser, 1996; Hyman and
Karsenti, 1996; Vernos and Karsenti, 1996; Waters and
Salmon, 1997), MAPs (Anderson et al., 1994; Masson and
Kreis, 1995; Vandre et al., 1991; Saunders et al., 1997;
Anderson and Karsenti, 1997) and mitotic protein kinases
(Glover et al., 1996; Gopalan et al., 1997; Kimura et al., 1997;
Lane and Nigg, 1997). The microtubule-association of MAPs
during mitosis is often regulated by phosphorylation (Brisch
et al., 1996; Ookata et al., 1997; reviewed by Hirokawa, 1994;
Maccioni and Cambiazo, 1995; Sorger et al., 1997), and it is
likely that phosphorylation is involved in the case of P23 as
well. The view that P23 may be a phosphoprotein is supported
by various reports demonstrating that it occurs as different
isoforms in vivo (Hughes et al., 1993; Celis et al., 1994;
Walsh et al., 1995; Sanchez et al., 1997). We have obtained
preliminary evidence indicating that the isoform pattern of
P23 is altered during mitosis (U.-A. Bommer, I. Demalte and
J.-C. Sanchez, unpublished observation) and that P23 is
phosphorylated by a mitotic kinase activity in vitro (results
not shown).
In this paper, we describe the properties of the growth-
related protein P23 as a tubulin binding protein, which is
temporarily associated with microtubules and the spindle
apparatus. Our overexpression data show that elevation of P23
levels leads to microtubule stabilisation, to alterations of cell
morphology and to distortions in the cell division process.
Further investigations will be necessary to identify the precise
role of P23 during its association with microtubules and with
the mitotic spindle.
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